Phreesia, Inc. (PHR) stock: key figures, P/E, revenue and dividend

Industrials · United States · ISIN US71944F1066

Price
12.53 USD
Market cap
770.53 m USD
P/E (2026)
313.25
P/S (2026)
1.60
Dividend yield
0.00 %
Net margin
0.48 %
Return on equity (ROE)
0.68 %
Return on assets (ROA)
0.35 %

Phreesia, Inc. financials

Fiscal year20252026
Revenue419.81 m USD480.59 m USD
Gross profit353.59 m USD409.23 m USD
Operating income-58.10 m USD-6.61 m USD
EBIT-56.14 m USD-4.16 m USD
Net income-58.53 m USD2.31 m USD
Diluted EPS – continuing operations-1.02 USD0.04 USD

Full history since 2017, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About Phreesia, Inc.

Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. It offers solutions including appointment optimization and referral management using AI-enabled workflows; and AI-based smart answering solution patient communications supported by voice and messaging solutions; integrated payment solutions embedded in intake and post-visit workflows, and financing solutions that enable healthcare organizations to accelerate cash collections while offering flexible payment options to patients; and digital intake and clinical data capture, patient engagement and activation tools, and measurement and analytics solutions. It also offers PhreesiaPads, a self-service intake tablets; and Arrivals Kiosks, which are on-site kiosks. The company serves a range of healthcare organizations including ambulatory practices, health systems, and hospitals, as well as life sciences companies, government entities, patient advocacy, public interest and not-for-profit and other organizations. Phreesia, Inc. was incorporated in 2005 and is based in Wilmington, Delaware.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.